NIAID Funding Opportunities: Myeloid-Derived Suppressor Cells as Potential Therapeutic Targets in TB/HIV

Funding Opportunities

• PAR-19-357, Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01, Clinical Trial Not Allowed)
• PAR-19-364, Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21, Clinical Trial Not Allowed)

For more, see Opportunities & Announcements. 

You can follow us on Twitter: @NIAIDFunding.